The improvement in CAL was highly significant within these groups from baseline to 6 and 9 months.
← all excerpts
Effects of recombinant human bone morphogenetic protein-2 compared to other biomaterials in the treatment of intrabony defects in periodontitis patients: A systematic review.
1
—
—